Cookies

Like most websites The Ophthalmologist uses cookies. In order to deliver a
personalized, responsive service and to improve the site, we remember and store information about how you use
it.
Learn more.

Farhad Hafezi

As a post-doc, Farhad Hafezi identified a gene that can completely inhibit light-induced retinal damage in mice. Today his clinical focus is on corneal and refractive laser surgery, and he is a pioneer of corneal collagen cross-linking (CXL). Hafezi was instrumental in building IROC in Zurich, where CXL technology underwent further clinical development.